The Kenya BioVax Institute Limited CEO, Dr. Michael Lusiola, represented the Cabinet Secretary The Ministry of Health during the Illumina-sponsored genomics workshop at ILRI, Nairobi. While making the remarks on behalf of the Cabinet Secretary, Dr. Lusiola spoke on the need for integrated approaches using innovative technologies to manage global health challenges.
“Genomics medicine is revolutionizing health care by offering prompt and accurate diagnosis, identifying a patient’s risk based on their genes, and providing personalized treatments”, he stated.
As part of its strategic goals, the The Ministry of Health, through the Kenya BioVax Institute Limited and Kenya Medical Research Institute, is establishing a regional hub for innovation, research, development, and commercialization of health products and technologies, including the application of genomics in human health.